Patents by Inventor Sumaira HASNAIN

Sumaira HASNAIN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD OF TREATING A METABOLIC DISORDER OF THE LIVER
    Publication number: 20200353048
    Abstract: A method of treating a metabolic disorder of the liver includes administering a therapeutic agent. The therapeutic agent includes an IL-22 polypeptide and an antigen-binding molecule. The IL-22 polypeptide is fused or otherwise conjugated, directly or indirectly, to the antigen-binding molecule, and the antigen-binding molecule is an antibody or antigen-binding fragment that includes heavy and light chain CDR sequences.
    Type: Application
    Filed: May 19, 2020
    Publication date: November 12, 2020
    Inventors: Michael McGuckin, Johannes Prins, Sumaira Hasnain
  • Modulation of cellular stress using a B-cell oxidative and/or endoplasmic reticulum stress inhibitor and a targeting agent
    Patent number: 10695406
    Abstract: Disclosed are compositions and methods for modulating oxidative and/or endoplasmic reticulum (OER) stress. More particularly, the present invention discloses compositions and methods that target OER stress inhibitors to pancreatic cells for treating diseases associated with oxidative and/or OER stress, including metabolic disorders such as diabetes.
    Type: Grant
    Filed: May 27, 2015
    Date of Patent: June 30, 2020
    Assignee: The University of Queensland
    Inventors: Michael McGuckin, Johannes Prins, Sumaira Hasnain
  • MODULATION OF CELLULAR STRESS
    Publication number: 20170143798
    Abstract: Disclosed are compositions and methods for modulating oxidative and/or endoplasmic reticulum (OER) stress. More particularly, the present invention discloses compositions and methods that target OER stress inhibitors to pancreatic cells for treating diseases associated with oxidative and/or OER stress, including metabolic disorders such as diabetes.
    Type: Application
    Filed: May 27, 2015
    Publication date: May 25, 2017
    Inventors: Michael McGUCKIN, Johannes PRINS, Sumaira HASNAIN